| INTRODUCTION
Pro-inflammatory cytokines and chemokines are essential for protective immunity. However, excessive or prolonged production of these factors can be associated with various pathological conditions.
Inflammation is known to prevent regulation of T cells and tolerance
to allografts after transplantation, which in turn precludes long-term allograft survival. 1 For example, inflammation early post-transplant is associated with the development of allograft vasculopathy. 2 Additionally, there is considerable interaction between innate inflammatory responses and activation of the coagulation system, 3 where the role of pro-inflammatory cytokines in the activation of coagulation is well studied. 4 Cytokines are known to induce and/or upregulate tissue factor expression on various cell types. For example, interleukin (IL)-1, IL-6, and tumor necrosis factor alpha (TNF-α) induce tissue factor expression by endothelial cells and circulating monocytes. 5, 6 We have shown that systemic inflammation in xenograft recipients (SIXR) precedes dysregulation of coagulation 7 and is sustained in xenograft recipients. 8 In organ xenograft recipients, innate immune cells infiltrating organ xenografts express tissue factor, a key factor in the activation of coagulation. 9 Furthermore, recipient immune cells and platelets in peripheral blood upregulate tissue factor expression early after xenotransplantation. 10 Complement activation is detrimental to xenograft survival, and regulation of the complement system is associated with prevention of early xenograft failure 11 and delayed xenograft rejection. 12 We have previously demonstrated that upregulation of IL-6 levels in xenograft recipients is associated with elevated levels of the inflammatory marker, C-reactive protein (C-RP), 7 while the administration of IL-6
receptor blockade prevents the upregulation of C-RP. 8 Additionally, administration of α1-antitrypsin (AAT) has been shown to prevent inflammatory responses in monkey allograft recipients.
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Prevention of increased pro-inflammatory cytokine production after xenotransplantation is likely to protect against dysregulation of the coagulation system and may allow reduction of immunosuppressive therapy after xenotransplantation. Accordingly, we evaluated the therapeutic effect of various anti-inflammatory agents on cytokine and chemokine levels, the inflammatory marker C-RP, and coagulation factors in pig artery patch and heart xenograft recipient baboons receiving T cell-directed immunosuppressive therapy.
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| METHODS

| Animals
Baboons (n=12) (Oklahoma University Health Sciences Center, Oklahoma City, OK) received either an artery patch graft (Group1, n=8) 8, 14 or a heart graft (Group2, n=4) 16 from genetically engineered pigs (Revivicor, Blacksburg, VA, USA).
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| Immunosuppressive and anti-inflammatory agents
All baboons received a T cell-directed immunosuppressive regimen based on costimulation blockade (anti-CD40 and/or CTLA4Ig). Tables 1 and 2 ). In Group2, two baboons received IL-6RA, while two recipients did not.
Group1 recipients received no corticosteroids, while Group2 recipients were given maintenance corticosteroids.
| Measurement of cytokines, chemokines, C-RP, D-dimers, and fibrinogen
Serum pro-inflammatory cytokines/chemokines (IFN-γ, TNF-α, 
K E Y W O R D S
chemokines, cytokines, heart, inflammation, pig, Xenotransplantation USA). Fibrinogen, D-dimers, and C-RP were measured by the Central Laboratory of Presbyterian Hospital, UPMC. 
| CFSE-mixed lymphocyte reaction (MLR)
Carboxyfluorescein
| TF expression mRNA (quantitative reverse transcription-polymerase chain reaction [RT-PCR])
RT-PCR was carried out as previously described. 8 Briefly, total RNA pellets were suspended in RNase-free water, followed by treatment with RNeasy Mini Kit (Qiagen, Hilden, Germany). RNA (<2 μg) from each sample was used for reverse transcription with High Capacity DNA Reverse
Transcription Kit (Thermo Fisher Scientific, Foster, CA, USA). Polymerase chain reaction (PCR) mixture was prepared using SYBR Green PCR Master Mix (Toyobo, Osaka, Japan). The primers used are as follows:
Baboon TF: 5-TGCTTTTACACAGCAGACACAGAGT-3 (forward) and
5-AAGACCCGTGCCAAGTACGT-3 (reverse).
Baboon β-actin: 5-TGGAAGAATGCGGCTCATATT-3 (forward) and 5
TACTATCCAATCCCTAGAAAGAACATG-3 (reverse).
Pig TF: 5-TTTACCAACTCGCCCCCCTTC-3 (forward) and 5-
AATGTGCCGTTCACCCTGACTAA-3 (reverse).
Pig β-actin: 5-CTCGATCATGAAGTGCGACTG-3 (forward) and 5-GTGA TCTCCTTCTGCATCCTGTC-3 (reverse). Thermal cycling conditions were 1 minute at 95°C, followed by 40 cycles of 95°C for 15 seconds, and 60°C for 1 minute, using ABI 7500 System (Applied Biosystems, Foster City, CA, USA).
| RESULTS
| T cell responses in xenograft recipients
In heart recipients, T cell responses were reduced after transplantation, compared to before transplantation (Table 1 ). In pig artery patch recipients, reduced T cell responses were observed, except in two recipients-B126 (belatacept only) and B65 (anti-CD40mAb only) where slight increases in T cell proliferation were observed.
| IFN-ү, TNF-α, IL-1, and IL-17 levels are not elevated in immunosuppressed xenograft recipients
Despite the variability in pre-Tx levels, IFN-ү, TNF-α, IL-1, and IL-17 levels did not increase in any artery patch recipient baboon (Group1), where they remained either comparable to or lower than pre-Tx, irrespective of the administration of anti-inflammatory agents ( Figure 1A) . Similarly, in heart recipients (Group2), levels remained either comparable to or lower F I G U R E 1 IFN-ү, TNF-α, IL-1, and IL-17 levels were not elevated after artery patch or heart xenotransplantation. IFN-ү, TNF-α, IL-1, and IL-17 serum levels were measured before and after transplantation in pig artery patch (A) and heart (B) xenograft recipients. After pig artery patch transplantation, recipients received no anti-inflammatory agent (None), CVF, IL-6RA (tocilizumab), or AAT. After heart transplantation, two baboons received IL-6RA, while two baboons did not. Serum samples were collected before transplantation (Pre-Tx), 4D (4 d), and 1W (1 wk), 2W (2 wk), 1M (1 mo), and 2-3M or 3-4M (2-3 or 3-4 mo) after transplantation. Levels were measured in pg/mL
F I G U R E 2 When no anti-inflammatory agent was administered, IL-6, IL-8, MCP-1, and sCD40L levels were increased after pig artery patch or heart transplantation. IL-6, IL-8, MCP-1, and sCD40L levels were measured before and after transplantation in artery patch (A) and heart (B) xenograft recipients (treated as for Figure 1 ). Serum samples were collected before transplantation (Pre-Tx), and 4D (4 d), 1W (1 wk), 2W (2 wk), 1M (1 mo), and 2-3M or 3-4M (2-3 or 3-4 mo) after transplantation. Levels were measured in pg/mL
| MCP-1, IL-6, IL-8, and sCD40L levels are elevated in immunosuppressed xenograft recipients
In Group1, with no administration of anti-inflammatory agents, MCP-1, IL-6, and IL-8 were elevated (Figure 2A ). After CVF administration, IL-6, IL-8, and MCP-1 remained lower than, or comparable to, pretransplant levels. After IL-6RA, MCP-1 levels were also elevated, while IL-6 became transiently elevated. After AAT, IL-6 and IL-8 gradually increased after transplantation. sCD40L levels were sporadically elevated in Group1 recipients, except in one recipient (B59; with CVF administration).
In Group2, IL-6 was transiently elevated after IL-6RA administration, while IL-8 remained comparable to before transplantation, except in one recipient (B57; with no IL-6RA administration), and MCP-1 gradually increased at 1 month in the same recipient baboon. sCD40L became elevated in only one baboon (B180; with IL-6RA administration).
| IL-6RA administration prevents increased C-RP levels
In Group1, C-RP remained low only after IL-6RA administration ( Figure 3A) , but was elevated when no anti-inflammatory agent, CVF, F I G U R E 3 A rise in C-reactive protein was only prevented by IL-6RA administration. C-RP levels were measured before and after transplantation in artery patch (A) and heart (B) xenograft recipients. Serum samples were collected before transplantation (Pre-Tx), and 1-2W (1-2 wk), 1M (1 mo), and 2M (2 mo) after transplantation. C-RP levels were measured in mg/dL F I G U R E 4 D-Dimers became elevated in all xenograft recipients irrespective of the administration of anti-inflammatory agents, whereas fibrinogen became elevated in only some recipients. D-Dimers and fibrinogen levels were measured before and after transplantation in artery patch (A) and heart (B) xenograft recipients. Plasma samples were collected before transplantation (Pre-Tx), and 4D (4 d or AAT had been administered. Similarly in Group2, IL-6RA administration prevented a rise in C-RP ( Figure 3B ).
| D-Dimers are elevated in all xenograft recipients
In Group1, D-dimer levels were elevated in all recipients ( Figure 4A) , irrespective of the administration of an anti-inflammatory agent. Also, in Group2, D-dimers became elevated in all recipients ( Figure 4B ), irrespective of the administration of IL-6RA.
| Fibrinogen levels in xenograft recipients
In Group1, fibrinogen levels were elevated when either no antiinflammatory agent or CVF had been administered, and also increased in one recipient after AAT (B65) ( Figure 4A ). The increase was prevented by IL-6RA administration. In Group2, higher levels of fibrinogen were prevented with IL-6RA administration after transplantation ( Figure 4B ).
| Pig and baboon TF mRNA levels in heart xenografts
The heart xenografts from B57 (no IL-6 receptor antagonist), B179, and B180 (with IL-6 receptor antagonist) demonstrated higher levels of pig TF mRNA than two naive pig hearts (controls). Additionally, baboon TF mRNA levels were detectable in the heart xenografts, but not in the naive pig hearts ( Figure 5 ). 8 This suggests that IL-6 receptor blockade does not prevent upregulation of either pig or baboon TF in xenograft recipients.
| DISCUSSION
In this small study, we evaluated the therapeutic effect of several anti-inflammatory agents on selected cytokine and chemokine levels in baboons with genetically engineered pig artery patch or heart xenografts. All recipients received anti-CD40mAb and/or belataceptbased immunosuppressive therapy. No significant increase in antipig T cell responses was observed (Table 1) , except in two recipients (B126 and B65) that received belatacept and anti-CD40mAb, respectively). However, no marked differences in cytokine production were observed in these two recipients in comparison with others in their respective groups.
Despite inhibition of anti-pig T cell responses after transplantation (Table 1) , complete prevention of increased pro-inflammatory cytokines and chemokines was not achieved after, when antiinflammatory agents were not administered. These observations suggest that regulation of the systemic inflammatory responses in xenograft recipients (SIXR) may require additional anti-inflammatory therapy and may be essential for long-term xenograft survival, as previously reported in rodent models of allo-transplantation. 1, 19 The biological relevance of increased levels of these pro-inflammatory factors remains uncertain.
It is yet to be determined whether the development of SIXR early or late after xenotransplantation is asso- ticosteroids and/or anti-inflammatory agents. C-RP is a well-studied marker of inflammation, and the role of IL-6 in promoting C-RP production is well known. We have previously shown that serum C-RP levels were elevated in xenograft recipients when immunosuppression was administered, but did not increase when no therapy was administered 7 . Notably, administration of IL-6RA maintained low levels of C-RP. 8 Our current observations confirm the therapeutic effect of F I G U R E 5 Porcine and baboon TF mRNA levels in naive pig hearts and pig heart xenografts. Porcine (gray) and baboon (black) TF mRNA levels were measured in naive pig hearts (left) and pig heart xenografts (right) at the time of euthanasia. Pig TF mRNA levels were elevated in heart xenografts obtained from B57 (no IL-6 receptor antagonist) and B179 and B180 (with IL-6 receptor antagonist), compared to naive pig hearts. Furthermore, baboon TF mRNA was detectable in the heart xenografts, but not in naive pig hearts. TF mRNA levels were normalized to those of β-actin IL-6RA on C-RP levels. However, IL-6RA administration did not prevent the upregulation of pig or baboon TF in organ xenografts in the current study.
Collectively, we show that elevated individual pro-inflammatory factors in xenograft recipients can be prevented by the administration of selected anti-inflammatory agents. However, the impact of anti-inflammatory agents on the prevention of SIXR and on xenograft
survival has yet to be determined. 
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